Chimerix reported $65.52M in Assets for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Ardelyx ARDX:US $ 129.41M 20.5M
Chimerix CMRX:US $ 65.52M 35.02M
Curis CRIS:US $ 140.74M 21.56M
Dynavax Technologies DVAX:US $ 1008.98M 30.27M
Emergent Biosolutions EBS:US $ 2780.4M 178.6M
Epizyme EPZM:US $ 312.19M 23.19M
Gilead Sciences GILD:US $ 63080M 4872M
Glaxosmithkline GSK:US $ 89689M 10586M
Life Technologies LIFE:US $ 104.78M 10.76M
Merk MRK:US $ 106668M 974M
Mirati Therapeutics MRTX:US $ 1421.3M 167.46M
Novavax NVAX:US $ 2834.88M 258.12M
Xoma XOMA:US $ 159.16M 7.4M